Showing results (21-30 of 78) with videos related to
Sort By:
Pageof 8
Molecular Immunology|June 6, 2017
No prolongation of skin allograft survival by immunoproteasome inhibition in miceSarah Mundt, Michael Basler, Birgit Sawitzki, et al.Frontiers in Immunology|January 2, 2023
Immunoproteasome inhibition attenuates experimental psoriasisMarta Del Rio Oliva, Mark Mellett, Michael BaslerJournal of Immunology (Baltimore, Md. : 1950)|March 18, 2021
Immunoproteasome Upregulation Is Not Required to Control Protein Homeostasis during Viral InfectionMichael Basler, Marleen Christ, Heike Goebel, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2009
The proteasome inhibitor bortezomib enhances the susceptibility to viral infectionMichael Basler, Christoph Lauer, Ulrike Beck, et al.Frontiers in Immunology|November 13, 2018
Immunoproteasome Inhibition Impairs T and B Cell Activation by Restraining ERK Signaling and ProteostasisChristian Schmidt, Thilo Berger, Marcus Groettrup, et al.The Journal of Biological Chemistry|August 15, 2003
Long-lived signal peptide of lymphocytic choriomeningitis virus glycoprotein pGP-CMarc Froeschke, Michael Basler, Marcus Groettrup, et al.Life Science Alliance|July 8, 2024
FAT10 inhibits TRIM21 to down-regulate antiviral type-I interferon secretionKritika Saxena, Katharina Inholz, Michael Basler, et al.International Journal of Molecular Sciences|June 19, 2024
The Significant Role of PA28αβ in CD8<sup>+</sup> T Cell-Mediated Graft Rejection Contrasts with Its Negligible Impact on the Generation of MHC-I LigandsKatharina Inholz, Ulrika Bader, Sarah Mundt, et al.Frontiers in Immunology|January 31, 2024
Corrigendum: Immunoproteasome inhibition attenuates experimental psoriasisMarta Del Rio Oliva, Mark Mellett, Michael BaslerMolecular Immunology|February 4, 2017
Immunoproteasome subunit deficiency has no influence on the canonical pathway of NF-κB activationAnnegret Bitzer, Michael Basler, Daniel Krappmann, et al.Pageof 8